Citius Pharmaceuticals, Inc.
Ticker: 1506251
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|---|---|---|
| INCOME | |||
| Revenue | 1.49-10.8% | 1.67-57.6% | 3.94 |
| Total Income | 1.49-10.8% | 1.67-57.6% | 3.94 |
| EXPENSES | |||
| Expenditure | 13.23-60.9% | 33.86+161.3% | 12.96 |
| Tax | -0.11+52.2% | -0.23-188.5% | 0.26 |
| PROFIT | |||
| PBT | -12.03+57.6% | -28.34-210.4% | -9.13 |
| Net Profit | -8.86+58.3% | -21.23-158.3% | -8.22 |
| KEY METRICS | |||
| OPM % | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% |
| EPS | -0.34+64.2% | -0.95-150.0% | -0.38 |
Corporate Events
No corporate events found.